Navigation Links
The Medical Affairs Company Expands Its Medical Communications Division
Date:2/23/2009

ATLANTA, Feb. 23 /PRNewswire/ -- The Medical Affairs Company LLC (TMAC(R)), the leading provider of outsourced medical science liaison (MSL) services, announced today a significant expansion of its medical communications division.

In response to an increasing client demand for clinician-staffed, project-based medical information and medical meeting surveillance services, TMAC has recently expanded the size of its Medical Communications division to better meet these needs. This expansion strengthens TMAC's ability to provide the pharmaceutical, biotechnology and medical device industries with a complete array of outsourcing capabilities for medical affairs activities.

    TMAC's Medical Communications capabilities include the provision of:

    -- Inbound and Outbound Medical Information Services
    -- Adverse Event (AE) and Product Complaint (PC) handling
    -- Medical Writing including standard letter, FAQ, SOP development
    -- Literature Surveillance and Summarization, including Pharmacovigilance
    -- Medical Meeting Surveillance and Support

"Expanding our core medical affairs offering to include clinician-staffed, highly customized Medical Communications services considerably enhances our Contract Medical Organization (CMO) model," states Dr. Evan Demestihas, TMAC's CEO. He adds, "Importantly, this expansion provides our clients with strategic, flexible and cost-efficient options. In today's economic environment, clients want to be assured that they are spending their budgets wisely and using their resources efficiently. TMAC's flexible offerings allow clients to better utilize their internal resources to focus on their current priorities, while we focus on implementing their medical affairs strategies with expertly trained healthcare professionals."

About The Medical Affairs Company

The Medical Affairs Company LLC (TMAC(R)) is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabilities for medical affairs activities. Providing both strategic and tactical medical science liaison support services in addition to medical science liaison consulting and medical communications support, TMAC is uniquely positioned to provide both unmatched value and service to the pharmaceutical industry. TMAC's greatest strength is their focus: medical and scientific affairs - it is their only business.

Please visit TMAC's website at: TheMedicalAffairsCompany.com.


'/>"/>
SOURCE The Medical Affairs Company LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee is ... honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. ... world’s leading conference and exposition for laboratory science, which will be held February ...
Breaking Biology Technology:
(Date:5/23/2017)... 23, 2017  Hunova, the first robotic gym for the rehabilitation and ... launched in Genoa, Italy . The first 30 robots ... the USA . The technology was developed and patented ... the IIT spin-off Movendo Technology thanks to a 10 million euro investment ... please click: ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
Breaking Biology News(10 mins):